Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	dynein light intermediate chain binding	CCDC88B DNAH17 DNAH8 DNAH11	3.82e-05	28	137	4	GO:0051959
GeneOntologyMolecularFunction	glutamine N-acyltransferase activity	GLYATL1 GLYATL1B	4.67e-05	2	137	2	GO:0047946
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH17 DNAH8 HTT DNAH11	1.17e-04	37	137	4	GO:0045505
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH17 DNAH8 DNAH11	2.39e-04	18	137	3	GO:0008569
GeneOntologyMolecularFunction	glycine N-acyltransferase activity	GLYATL1 GLYATL1B	4.61e-04	5	137	2	GO:0047961
Domain	TPR-like_helical_dom	IFT140 FEM1C TRANK1 HELZ STIP1 LONRF3 FEM1A SMG6 WDTC1	4.74e-05	233	134	9	IPR011990
Domain	DVL-1	DVL1P1 DVL1	5.11e-05	2	134	2	IPR008340
Domain	Ubiquitin-rel_dom	UBQLN1 UBL3 FRMPD2 USP24 DVL1 DGKQ SACS TP53BP2	5.52e-05	184	134	8	IPR029071
Domain	-	FEM1C TRANK1 HELZ STIP1 LONRF3 FEM1A SMG6 WDTC1	1.26e-04	207	134	8	1.25.40.10
Domain	STPPase_N	PPP1CA PPP1CC	1.53e-04	3	134	2	IPR031675
Domain	STPPase_N	PPP1CA PPP1CC	1.53e-04	3	134	2	PF16891
Domain	ARM-type_fold	UBQLN1 USP24 TSC2 CTIF HEATR1 XPO5 FHOD1 AP3D1 TBCD HTT	1.70e-04	339	134	10	IPR016024
Domain	TPR_REGION	IFT140 FEM1C TRANK1 STIP1 LONRF3 FEM1A WDTC1	1.90e-04	165	134	7	PS50293
Domain	TPR	IFT140 FEM1C TRANK1 STIP1 LONRF3 FEM1A WDTC1	1.90e-04	165	134	7	PS50005
Domain	Dishevelled	DVL1P1 DVL1	3.04e-04	4	134	2	PF02377
Domain	Dishevelled_fam	DVL1P1 DVL1	3.04e-04	4	134	2	IPR008339
Domain	PBC	PBX1 PBX2	3.04e-04	4	134	2	PF03792
Domain	Dishevelled_protein_dom	DVL1P1 DVL1	3.04e-04	4	134	2	IPR003351
Domain	PBX	PBX1 PBX2	3.04e-04	4	134	2	IPR005542
Domain	RhoGAP	ARHGAP10 ARHGAP35 CHN1 FAM13B	1.02e-03	62	134	4	SM00324
Domain	DIX	DVL1P1 DVL1	1.05e-03	7	134	2	PF00778
Domain	DIX	DVL1P1 DVL1	1.05e-03	7	134	2	IPR001158
Domain	DIX	DVL1P1 DVL1	1.05e-03	7	134	2	PS50841
Domain	DAX	DVL1P1 DVL1	1.05e-03	7	134	2	SM00021
Domain	RhoGAP	ARHGAP10 ARHGAP35 CHN1 FAM13B	1.09e-03	63	134	4	PF00620
Domain	-	TSC2 HEATR1 XPO5 FHOD1 AP3D1 TBCD HTT	1.12e-03	222	134	7	1.25.10.10
Domain	RhoGAP_dom	ARHGAP10 ARHGAP35 CHN1 FAM13B	1.15e-03	64	134	4	IPR000198
Domain	RHOGAP	ARHGAP10 ARHGAP35 CHN1 FAM13B	1.15e-03	64	134	4	PS50238
Domain	-	ARHGAP10 ARHGAP35 CHN1 FAM13B	1.15e-03	64	134	4	1.10.555.10
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	IFT140 ANK3 MYO1E ARHGAP10 RBMS1 ATG2B CDH23 MCM3 TSC2 HEATR1 EIF3CL PPP1CA DHX9 PPP1CC CNNM4 XPO5 HELZ VPS51 SNRNP200 TP53BP2 TBCD CDK4 WDTC1	2.87e-09	1321	139	23	27173435
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ZC3H14 ANK3 RBM10 ATG2B USP24 DVL1 MCM3 HEATR1 ARHGAP35 PPP1CA PEAK1 SNRNP200 TP53BP2 HTT	4.88e-08	549	139	14	38280479
Pubmed	A human MAP kinase interactome.	IFT140 ANK3 CNTRL NEB CCDC88B FAM13B CDC42BPB FHOD1 MCM3AP HELZ MAPK7 SLC4A4 SNRNP200	8.70e-08	486	139	13	20936779
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PDE2A UBQLN1 ANK3 MYO1E PPRC1 RHOBTB3 MCF2L2 HECTD4 APBB2 TSC2 CACHD1 CDC42BPB SACS UBE3A ZNF197 DNM3 PBX1 PBX2 SNRNP200 SCAI	2.11e-07	1285	139	20	35914814
Pubmed	CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.	RNF213 TSC2 FHOD1 MCM3AP HELZ TBCD HTT	2.15e-07	104	139	7	31240132
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ATP6V1E1 PDE2A ANK3 MYO1E ARHGAP35 CDC42BPB EIF3CL PPP1CA DHX9 PPP1CC SACS STON2 STIP1 PEAK1 SLC4A4 VPS51 SNRNP200 AP3D1 TP53BP2 SCAI DNAH11	2.68e-07	1431	139	21	37142655
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	IFT140 MCF2L2 CACHD1 BAHD1 MCM3AP SNRNP200 WDTC1	9.81e-07	130	139	7	12421765
Pubmed	Molecular mechanisms underlying the interaction of protein phosphatase-1c with ASPP proteins.	PPP1CA PPP1CC TP53BP2	1.24e-06	6	139	3	23088536
Pubmed	Inhibitory member of the apoptosis-stimulating proteins of the p53 family (iASPP) interacts with protein phosphatase 1 via a noncanonical binding motif.	PPP1CA PPP1CC TP53BP2	1.24e-06	6	139	3	21998301
Pubmed	Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.	DNAH17 DNAH8 DNAH11	2.16e-06	7	139	3	31178125
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PDE2A MYO1E PPRC1 HECTD4 DVL1 DGKQ TSC2 ARHGAP35 CDC42BPB BAHD1 PLEKHG1 MCM3AP FEM1A AP3D1 TBCD HTT SMG6	2.18e-06	1105	139	17	35748872
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	POLB USP24 DVL1 HEATR1 ARHGAP35 CDC42BPB DHX9 SACS XPO5 STIP1 TBCD	5.60e-06	498	139	11	36634849
Pubmed	FEM1 proteins are ancient regulators of SLBP degradation.	CTIF FEM1C FEM1A	7.34e-06	10	139	3	28118078
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	PDE2A ANK3 HECTD4 MCM3 TSC2 CDC42BPB PPP1CA PPP1CC UBE3A STON2 DNM3 STIP1 SLC4A4 TP53BP2 SMG6	7.76e-06	963	139	15	28671696
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ANK3 ARHGAP10 FRMPD2 INSR HECTD4 APBB2 RNF213 CTIF AHCYL2 FOXN3 ARHGAP35 CDC42BPB F7 CNNM4 PBX1 PBX2 TBCD HTT SMG6	7.94e-06	1489	139	19	28611215
Pubmed	Identification of the human testis protein phosphatase 1 interactome.	PPP1CA PPP1CC SPOCD1 TP53BP2 SMG6	8.08e-06	68	139	5	21382349
Pubmed	Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation.	MCM3 PPP1CA PPP1CC XPO5 DNM3 STIP1 SNRNP200	8.50e-06	180	139	7	30110629
Pubmed	A directed protein interaction network for investigating intracellular signal transduction.	IFT140 ATP6V1E1 DVL1 MYOZ3 MCM3 TSC2 CHN1 BAHD1 SERPINA4 MID1IP1 UBE3A MCM3AP FGB VPS51 TP53BP2 CDK4	1.17e-05	1124	139	16	21900206
Pubmed	Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins.	PDE3A ARHGAP10 HECTD4 MCM3 TSC2 DHX9 TP53BP2	1.21e-05	190	139	7	15161933
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	ANK3 ATG2B USP24 DVL1 AHCYL2 ARHGAP35 CDC42BPB EIF3CL PPP1CA PPP1CC UBE3A HELZ STIP1 PEAK1 SLC4A4 VPS51	1.37e-05	1139	139	16	36417873
Pubmed	Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1.	DVL1 PPP1CA PPP1CC MOB1B STIP1 PEAK1 AP3D1 TP53BP2	1.39e-05	270	139	8	24366813
Pubmed	Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1.	UBQLN1 BCL2L10	1.59e-05	2	139	2	22233804
Pubmed	Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy.	PDE2A PDE3A	1.59e-05	2	139	2	26095046
Pubmed	E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6.	TSC2 UBE3A	1.59e-05	2	139	2	18298802
Pubmed	MCM3AP, a novel acetyltransferase that acetylates replication protein MCM3.	MCM3 MCM3AP	1.59e-05	2	139	2	11258703
Pubmed	Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53.	PPP1CC TP53BP2	1.59e-05	2	139	2	8549741
Pubmed	Fibrinogen and factor VII promoter polymorphisms in women with preeclampsia.	F7 FGB	1.59e-05	2	139	2	12151156
Pubmed	Spermiogenesis is impaired in mice bearing a targeted mutation in the protein phosphatase 1cgamma gene.	PPP1CA PPP1CC	1.59e-05	2	139	2	9882500
Pubmed	Human homologue sequences to the Drosophila dishevelled segment-polarity gene are deleted in the DiGeorge syndrome.	DVL1P1 DVL1	1.59e-05	2	139	2	8644734
Pubmed	Coagulation gene polymorphisms as risk factors for myocardial infarction in young Indian Asians.	F7 FGB	1.59e-05	2	139	2	16049588
Pubmed	Identification of a novel MCM3-associated protein that facilitates MCM3 nuclear localization.	MCM3 MCM3AP	1.59e-05	2	139	2	9712829
Pubmed	Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation.	PBX1 PBX2	1.59e-05	2	139	2	7910944
Pubmed	Identification of human FEM1A, the ortholog of a C. elegans sex-differentiation gene.	FEM1C FEM1A	1.59e-05	2	139	2	11733146
Pubmed	PP-1α and PP-1γ display antagonism and differential roles in tumorigenicity of lung cancer cells.	PPP1CA PPP1CC	1.59e-05	2	139	2	23176181
Pubmed	Ubiquilin interacts and enhances the degradation of expanded-polyglutamine proteins.	UBQLN1 HTT	1.59e-05	2	139	2	17603015
Pubmed	Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A.	UBE3A HTT	1.59e-05	2	139	2	24706802
Pubmed	Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.	PDE2A PDE3A	1.59e-05	2	139	2	12038792
Pubmed	A novel nuclear phosphoprotein, GANP, is up-regulated in centrocytes of the germinal center and associated with MCM3, a protein essential for DNA replication.	MCM3 MCM3AP	1.59e-05	2	139	2	10733502
Pubmed	Pbx1 is required for adult subventricular zone neurogenesis.	PBX1 PBX2	1.59e-05	2	139	2	27226325
Pubmed	Structure, expression, and chromosomal localization of the human gene encoding a germinal center-associated nuclear protein (GANP) that associates with MCM3 involved in the initiation of DNA replication.	MCM3 MCM3AP	1.59e-05	2	139	2	11024281
Pubmed	The MCM3 acetylase MCM3AP inhibits initiation, but not elongation, of DNA replication via interaction with MCM3.	MCM3 MCM3AP	1.59e-05	2	139	2	12226073
Pubmed	Genetic polymorphisms modify the response of factor VII to oral contraceptive use: an example of gene-environment interaction.	F7 FGB	1.59e-05	2	139	2	12616980
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	ATP6V1E1 PDE3A UBQLN1 MYO1E USP24 MCM3 EIF3CL PPP1CA DHX9 PPP1CC XPO5 UBE3A STIP1 HERC4 SNRNP200 AP3D1 TBCD HTT	2.12e-05	1455	139	18	22863883
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH17 DNAH8 DNAH11	2.20e-05	14	139	3	9373155
Pubmed	Oocyte-expressed yes-associated protein is a key activator of the early zygotic genome in mouse.	BCL2L10 SLC39A4 CNNM4 ALPP	3.21e-05	45	139	4	26902285
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	RBM10 ATG2B MCM3 ARHGAP35 NEB DHX9 PPP1CC NBPF14 SNRNP200 SMG6	4.36e-05	513	139	10	25798074
Pubmed	Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington's disease.	UBE3A HTT	4.75e-05	3	139	2	28007908
Pubmed	The TALE homeodomain protein Pbx2 is not essential for development and long-term survival.	PBX1 PBX2	4.75e-05	3	139	2	15169896
Pubmed	Mutually exclusive binding of PP1 and RNA to AKAP149 affects the mitochondrial network.	PPP1CA PPP1CC	4.75e-05	3	139	2	19074462
Pubmed	1E7-03, a low MW compound targeting host protein phosphatase-1, inhibits HIV-1 transcription.	PPP1CA PPP1CC	4.75e-05	3	139	2	25073485
Pubmed	The direct binding of the catalytic subunit of protein phosphatase 1 to the PKR protein kinase is necessary but not sufficient for inactivation and disruption of enzyme dimer formation.	PPP1CA PPP1CC	4.75e-05	3	139	2	12138106
Pubmed	Chromosomal localization of human, rat, and mouse protein phosphatase type 1 beta catalytic subunit genes (PPP1CB) by fluorescence in situ hybridization.	PPP1CA PPP1CC	4.75e-05	3	139	2	7857673
Pubmed	Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3.	PDE2A PDE3A	4.75e-05	3	139	2	17704206
Pubmed	Dynamic targeting of protein phosphatase 1 within the nuclei of living mammalian cells.	PPP1CA PPP1CC	4.75e-05	3	139	2	11739654
Pubmed	A novel pbx family member expressed during early zebrafish embryogenesis forms trimeric complexes with Meis3 and Hoxb1b.	PBX1 PBX2	4.75e-05	3	139	2	10679934
Pubmed	Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin.	TSC2 UBE3A	4.75e-05	3	139	2	15175323
Pubmed	Characterization of protein phosphatases in mouse oocytes.	PPP1CA PPP1CC	4.75e-05	3	139	2	9882488
Pubmed	Homeodomain proteins MEIS1 and PBXs regulate the lineage-specific transcription of the platelet factor 4 gene.	PBX1 PBX2	4.75e-05	3	139	2	12609849
Pubmed	FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome.	FEM1C FEM1A	4.75e-05	3	139	2	18757445
Pubmed	Iloprost- and isoproterenol-induced increases in cAMP are regulated by different phosphodiesterases in erythrocytes of both rabbits and humans.	PDE2A PDE3A	4.75e-05	3	139	2	19252089
Pubmed	Association of beta-fibrinogen and factor VII polymorphism with plasma fibrinogen and factor VII levels, and no association of PAI-1 polymorphism with plasma PAI-1 levels in hemodialysis patients.	F7 FGB	4.75e-05	3	139	2	12141403
Pubmed	Protein phosphatase 1 (PP1) is a post-translational regulator of the mammalian circadian clock.	PPP1CA PPP1CC	4.75e-05	3	139	2	21712997
Pubmed	NOM1 targets protein phosphatase I to the nucleolus.	PPP1CA PPP1CC	4.75e-05	3	139	2	17965019
Pubmed	Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis.	MCM3 DHX9	4.75e-05	3	139	2	28460433
Pubmed	The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver.	PBX1 PBX2	4.75e-05	3	139	2	11468159
Pubmed	Prep1, a novel functional partner of Pbx proteins.	PBX1 PBX2	4.75e-05	3	139	2	9482739
Pubmed	Myr 8, a novel unconventional myosin expressed during brain development associates with the protein phosphatase catalytic subunits 1alpha and 1gamma1.	PPP1CA PPP1CC	4.75e-05	3	139	2	11588169
Pubmed	MCM3-binding GANP DNA-primase is associated with a novel phosphatase component G5PR.	MCM3 MCM3AP	4.75e-05	3	139	2	12167160
Pubmed	Global genetic analysis in mice unveils central role for cilia in congenital heart disease.	IFT140 PDE2A CNTRL MAPK7 DNAH11	5.27e-05	100	139	5	25807483
Pubmed	Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor.	PIK3AP1 PPP1CA PPP1CC DNM3 PEAK1	6.06e-05	103	139	5	21706016
Pubmed	Mapping brain gene coexpression in daytime transcriptomes unveils diurnal molecular networks and deciphers perturbation gene signatures.	CHN1 PPP1CA TRANK1 HTT	6.15e-05	53	139	4	36265442
Pubmed	A quantitative atlas of mitotic phosphorylation.	RBM10 RNF213 EIF3CL	6.78e-05	20	139	3	18669648
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	RBM10 HECTD4 RNF213 CTIF DHX9 XPO5 HELZ	6.95e-05	250	139	7	33536335
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	ATP6V1E1 RBM10 MCM3 EIF3CL DHX9 PPP1CC UBE3A STIP1 HERC4 SNRNP200 TBCD	7.88e-05	665	139	11	30457570
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	ZC3H14 ARHGAP10 MCF2L2 MCM3 AHCYL2 HEATR1 ARHGAP35 CHN1 FAM13B PLEKHG1 DNM3 STIP1 PEAK1	8.30e-05	916	139	13	32203420
Pubmed	Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling.	PPP1CA PPP1CC	9.47e-05	4	139	2	23499489
Pubmed	Nuclear targeting of protein phosphatase-1 by HIV-1 Tat protein.	PPP1CA PPP1CC	9.47e-05	4	139	2	16131488
Pubmed	Identification of the spermatogenic zip protein Spz1 as a putative protein phosphatase-1 (PP1) regulatory protein that specifically binds the PP1cgamma2 splice variant in mouse testis.	PPP1CA PPP1CC	9.47e-05	4	139	2	15226296
Pubmed	Regulation of ENaC in mice lacking renal insulin receptors in the collecting duct.	INSR SCNN1G	9.47e-05	4	139	2	23558339
Pubmed	Nuclear protein phosphatase-1 regulates HIV-1 transcription.	PPP1CA PPP1CC	9.47e-05	4	139	2	12788939
Pubmed	Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx.	PPP1CA PPP1CC	9.47e-05	4	139	2	23277204
Pubmed	The neuronal actin-binding proteins, neurabin I and neurabin II, recruit specific isoforms of protein phosphatase-1 catalytic subunits.	PPP1CA PPP1CC	9.47e-05	4	139	2	12016225
Pubmed	Inhibitor-2 regulates protein phosphatase-1 complexed with NimA-related kinase to induce centrosome separation.	PPP1CA PPP1CC	9.47e-05	4	139	2	12221103
Pubmed	Regulation of insulin-like growth factor receptors by Ubiquilin1.	UBQLN1 INSR	9.47e-05	4	139	2	29054976
Pubmed	Phosphorylation of protein phosphatase 1 by cyclin-dependent protein kinase 5 during nerve growth factor-induced PC12 cell differentiation.	PPP1CA PPP1CC	9.47e-05	4	139	2	17202132
Pubmed	Synphilin-1A is a phosphoprotein phosphatase 1-interacting protein and affects PPP1 sorting to subcellular compartments.	PPP1CA PPP1CC	9.47e-05	4	139	2	24902662
Pubmed	cDNA characterization and chromosomal mapping of two human homologues of the Drosophila dishevelled polarity gene.	DVL1P1 DVL1	9.47e-05	4	139	2	8817329
Pubmed	Characterization of the neuronal targeting protein spinophilin and its interactions with protein phosphatase-1.	PPP1CA PPP1CC	9.47e-05	4	139	2	10194355
Pubmed	Human dishevelled genes constitute a DHR-containing multigene family.	DVL1P1 DVL1	9.47e-05	4	139	2	9192851
Pubmed	PBX1 acts as terminal selector for olfactory bulb dopaminergic neurons.	PBX1 PBX2	9.47e-05	4	139	2	32156753
Pubmed	Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc.	SACS UBE3A	9.47e-05	4	139	2	23671107
Pubmed	Non-canonical Wnt signaling induces ubiquitination and degradation of Syndecan4.	DVL1P1 DVL1	9.47e-05	4	139	2	20639201
Pubmed	Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis.	F7 FGB	9.47e-05	4	139	2	18253477
Pubmed	NIMA-related kinase 2 (Nek2), a cell-cycle-regulated protein kinase localized to centrosomes, is complexed to protein phosphatase 1.	PPP1CA PPP1CC	9.47e-05	4	139	2	10880350
Pubmed	Small molecules targeted to a non-catalytic "RVxF" binding site of protein phosphatase-1 inhibit HIV-1.	PPP1CA PPP1CC	9.47e-05	4	139	2	22768081
Pubmed	E6AP AZUL interaction with UBQLN1/2 in cells, condensates, and an AlphaFold-NMR integrated structure.	UBQLN1 UBE3A	9.47e-05	4	139	2	36827983
Pubmed	Interaction of inhibitor-2 with the catalytic subunit of type 1 protein phosphatase. Identification of a sequence analogous to the consensus type 1 protein phosphatase-binding motif.	PPP1CA PPP1CC	9.47e-05	4	139	2	10807923
Pubmed	Pbx/Meis deficiencies demonstrate multigenetic origins of congenital heart disease.	PBX1 PBX2	9.47e-05	4	139	2	18723445
Pubmed	Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.	RNF213 EIF3CL	9.47e-05	4	139	2	18187866
Pubmed	PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1.	PBX1 PBX2	9.47e-05	4	139	2	1682799
GeneFamily	Dyneins, axonemal	DNAH17 DNAH8 DNAH11	9.35e-05	17	96	3	536
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP10 ARHGAP35 CHN1 FAM13B	1.43e-04	50	96	4	721
GeneFamily	Ankyrin repeat domain containing	ANK3 FEM1C POTEC TRANK1 FEM1A TP53BP2	1.84e-03	242	96	6	403
GeneFamily	Protein phosphatase catalytic subunits\|EF-hand domain containing	PPP1CA PPP1CC	2.09e-03	13	96	2	693
Coexpression	PARENT_MTOR_SIGNALING_UP	IFT140 RBM10 KLF3 TSC2 KLHL20 DHX9 TRANK1 CATSPER2 CPQ FGB HELZ SLC4A4 ENPEP SERPIND1	1.73e-06	567	137	14	M16909
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ZC3H14 GALNT1 UBL3 RBMS1 RHOBTB3 USP24 APBB2 CTIF FOXN3 ARHGAP35 KLHL20 SACS UBE3A HELZ NBPF14 HERC4 TP53BP2	2.52e-06	856	137	17	M4500
Coexpression	GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN	INSR AHCYL2 MEFV EVA1B CPQ HERC4 MXI1 WDTC1	1.04e-05	199	137	8	M5726
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A PCDH12 CHN1 PLEKHG1 FAR2 RBMS3 DNM3 PBX1 TBCD	9.45e-09	191	139	9	f663131a4810584c5854bd64ee7991a237b7707f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 RBMS3 DNM3 PEAK1 PBX1 TBCD	1.08e-08	194	139	9	f76808666fb875fc787751cbfd924d9be20a8192
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 RBMS3 DNM3 PEAK1 PBX1 TBCD	1.08e-08	194	139	9	a52c5906fce43c2f72cf7e463a3d15cde06431f6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A POLB PCDH12 CHN1 FAR2 DNM3 PBX1 TBCD	1.80e-07	194	139	8	ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 RBMS3 DNM3 PEAK1 PBX1	1.80e-07	194	139	8	f5706ab6bc803606c4640ddd606617e4e797ccc9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 RBMS3 DNM3 PBX1 TBCD	1.80e-07	194	139	8	fa6d51f36a3dae8763a595c20892987ed454c0f0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 DNM3 PEAK1 PBX1 TBCD	1.94e-07	196	139	8	ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 RBMS3 DNM3 PEAK1 PBX1	2.10e-07	198	139	8	0a172c6d997c7cfbad34b56e80121bd104dee67d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A GALNT1 POLB FAR2 RBMS3 PBX1 TBCD	1.18e-06	172	139	7	c056d44e2e130ceccadfcdceb192a7f095d779c8
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_1\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PDE2A PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	1.60e-06	180	139	7	3c605d6adb4199963532f3639f2c768f7e575152
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_1\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDE2A PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	1.60e-06	180	139	7	3d52ca0568f9c0d6359b302ff5ff41b075f78597
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRINP3 ANK3 MYO1E RHOBTB3 MOB1B SCNN1G SLC4A4	1.66e-06	181	139	7	aa233b652921848af2257cc3687a7a09c3acfb67
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRINP3 ANK3 MYO1E CDC42BPB MOB1B SCNN1G SLC4A4	1.92e-06	185	139	7	a0a629e5d2b65f670ea907bd3f5e3caf17687d8f
ToppCell	10x5'-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes\|GI_small-bowel / Manually curated celltypes from each tissue	PIK3AP1 ACRBP INSR CDH23 MEFV EVA1B XPO5	1.99e-06	186	139	7	a16ecf70271894a842925f232009e2623d16947e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOK6 PDE3A ARHGAP10 CACHD1 RBMS3 ANGPT4 DNAH11	2.06e-06	187	139	7	ec4b694487cc446999c7b27b119950a4f252c4b3
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOK6 PDE3A ARHGAP10 CACHD1 RBMS3 ANGPT4 DNAH11	2.06e-06	187	139	7	530e4e6d91b5c0d9aa4543caa2b734a1674c5788
ToppCell	remission-Platelet\|World / disease stage, cell group and cell class	PDE3A ACRBP MOB1B STON2 DNM3 PBX1 SPOCD1	2.13e-06	188	139	7	fa69f20ef6b8ce620ba342f0984d40ddf259bc3f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CDH23 CHN1 FAR2 RBMS3 DNM3 TBCD	2.45e-06	192	139	7	1ee4783051ec94ea94600f040edcb385fc4289f1
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CACHD1 CHN1 PLEKHG1 DNM3 PBX1 TBCD	2.45e-06	192	139	7	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CACHD1 CHN1 PLEKHG1 DNM3 PBX1 TBCD	2.54e-06	193	139	7	52e918884877b6659cdca0496390e440f73694a9
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CACHD1 PLEKHG1 DNM3 PEAK1 PBX1 TBCD	2.62e-06	194	139	7	74a9fdb73f279bebb6337510deab9aaaf9f7e957
ToppCell	10x5'-blood-Hematopoietic_Erythro-Mega-Megakaryocyte_early\|blood / Manually curated celltypes from each tissue	PDE3A ACRBP MOB1B STON2 DNM3 PBX1 SPOCD1	2.62e-06	194	139	7	63dea7d630962761a70aa88e720ee35c22cbc81a
ToppCell	10x5'-blood-Hematopoietic_Erythro-Mega\|blood / Manually curated celltypes from each tissue	PDE3A ACRBP MOB1B STON2 DNM3 PBX1 SPOCD1	2.62e-06	194	139	7	d0e7d35b5086834929c4bd39d4c6719b2d5fc71e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 DNM3 PBX1 TBCD	2.62e-06	194	139	7	b490fffc94f005dff9a34ce34d80ca776e3a1387
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 RBMS3 DNM3 TBCD	2.81e-06	196	139	7	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	COVID-19-kidney-VWF+PLVAP+VCAM1+EC\|kidney / Disease (COVID-19 only), tissue and cell type	PDE2A CHN1 PLEKHG1 FAR2 RBMS3 DNM3 PBX1	2.81e-06	196	139	7	ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CACHD1 CHN1 PLEKHG1 RBMS3 DNM3 PBX1	2.81e-06	196	139	7	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 RBMS3 PBX1 TBCD	2.81e-06	196	139	7	b8f89a50114932c08fc5daac4b549adfe9df8e66
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 RBMS3 DNM3 TBCD	2.81e-06	196	139	7	9606ea7e42f707e69ea891b3521037613b9675f5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CACHD1 CHN1 PLEKHG1 RBMS3 DNM3 PBX1	2.81e-06	196	139	7	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 RBMS3 PBX1 TBCD	2.81e-06	196	139	7	d0ff1082898d2db47c88d2678466514e9e9193d3
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A INSR CACHD1 CHN1 PLEKHG1 DNM3 PBX1	2.90e-06	197	139	7	c10dd1aaec01fb662eac83dfde90e3e426665d65
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A INSR CACHD1 CHN1 PLEKHG1 DNM3 PBX1	2.90e-06	197	139	7	2844dbcd0a673ed81c99920aa45858651a00736d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 RBMS3 DNM3 PBX1	3.00e-06	198	139	7	07701c73137947ed4a27e225975329235bbb8734
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 RBMS3 DNM3 PBX1	3.00e-06	198	139	7	fa84bf8533d1b91d2c2bcf06b710670605072b89
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	GALNT1 UBL3 CNTRL INSR KLF3 PBX1 AP3D1	3.10e-06	199	139	7	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	FAM184A PDE2A SLC39A4 NEB CNNM4 PBX1	1.38e-05	166	139	6	6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A MYO1E RBMS1 MCF2L2 APBB2 RBMS3	1.58e-05	170	139	6	876b84740e15399bfff2b9c7f0b80fd759bbdb3f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A MYO1E RBMS1 MCF2L2 APBB2 RBMS3	1.58e-05	170	139	6	1f8738acf439d893880db7e1fdc9b3615ca00c39
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_Erythro-Mega\|lymph-node_spleen / Manually curated celltypes from each tissue	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	1.86e-05	175	139	6	5ca3369ce2c2bb88ba097260195aecd67cec1a3a
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_Erythro-Mega-Megakaryocyte_early\|lymph-node_spleen / Manually curated celltypes from each tissue	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	1.92e-05	176	139	6	50fe3fd862dd6a6550ebb8c27f337cde468efedc
ToppCell	(9)_Platelet\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	1.98e-05	177	139	6	0830944c43de300815831a9e2b2fce40965e7d12
ToppCell	(9)_Platelet\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	1.98e-05	177	139	6	e63d01c7fce4fa1256212fa7e95f74281edb3a01
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.05e-05	178	139	6	f5d83ad082e31d5601890d245b9fb4f9ef6a062b
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.05e-05	178	139	6	a2a8fc14f492a4695e6991a357b6626145f1bf7f
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.11e-05	179	139	6	510927794bbd21814eba75286e0801eb1fd2e8a6
ToppCell	PBMC-Convalescent-Hematopoietic\|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.11e-05	179	139	6	3b1616e974ea7792ff5c37da3b0281f28edfbb56
ToppCell	PBMC-Convalescent-Hematopoietic\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.11e-05	179	139	6	35271a4396a533f6d960ce55d171a32d9d2fd1a4
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.11e-05	179	139	6	906a5ebbbac660b6fd498ced09d0ada40a3e64af
ToppCell	COVID-19_Convalescent-Hematopoietic_Mega-Platelet\|COVID-19_Convalescent / Disease group, lineage and cell class	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.18e-05	180	139	6	deed53167504c91220b35a63366ed7d8f02a5254
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CABP1 ONECUT2 BRINP3 ARHGAP10 CHN1 ENPEP	2.18e-05	180	139	6	5391d23817f5cc88a0871ddb98968897c839f464
ToppCell	COVID-19_Convalescent-Hematopoietic_Mega\|COVID-19_Convalescent / Disease group, lineage and cell class	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.18e-05	180	139	6	17323d382ae322e388e230fdad13e3464ea73e8e
ToppCell	Influenza_Severe-Platelet\|Influenza_Severe / Disease group and Cell class	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.25e-05	181	139	6	4d037b098bb6f780ed8b15c0ec23a6f4d86bf45a
ToppCell	remission-Platelet\|remission / disease stage, cell group and cell class	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.32e-05	182	139	6	65e2798aacd670cbc3a8c8e9d1a2f7768513bb70
ToppCell	10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Megakaryocyte_early\|bone_marrow / Manually curated celltypes from each tissue	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.39e-05	183	139	6	3cc9f3dc3bc4bde1d3408b0a6ba58e135a11036d
ToppCell	COVID-19-Heart-EC_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CABP1 APBB2 CHN1 PLEKHG1 DNM3 TBCD	2.39e-05	183	139	6	ff95382cfed592190d0636d2b750328471f82e0d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 DNM3 PBX1	2.47e-05	184	139	6	688428103e8b19f45f2f65d70a0f30c904c8411c
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CABP1 ONECUT2 BRINP3 ARHGAP10 CHN1 ENPEP	2.47e-05	184	139	6	6475a43201b136dcc9b113d2ca4cfa154ed9d65d
ToppCell	control-Others-Megakaryocytes\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.47e-05	184	139	6	213915f2889ce8ecbe5f7b19bc2b24ed8c5efe1d
ToppCell	megakaryocytic\|World / Lineage and Cell class	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.47e-05	184	139	6	b1c630ca2189d9d49402a5621b57618976fbea5c
ToppCell	COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	PDE2A MYO1E CACHD1 CHN1 PLEKHG1 DNM3	2.54e-05	185	139	6	f5e14181f45c37d13ee9e017a4c8bc248c353676
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet-plt_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.62e-05	186	139	6	107bc473f5e57238390f8e0ab9f7263a8f93948c
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet-plt_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.62e-05	186	139	6	13a9ddcf93b0c4319ab9d484af5e2056e9754caa
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A PCDH12 CHN1 PLEKHG1 DNM3 TBCD	2.70e-05	187	139	6	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	DOK6 BRINP3 PDE3A ARHGAP10 CHN1 RBMS3	2.70e-05	187	139	6	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	T_cells-ISG-high_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	FAM184A ANK3 RNF213 TRANK1 FAR2 MASTL	2.78e-05	188	139	6	6f8946d4710f6e32c937213f99b790b098b8819c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	BRINP3 ANK3 AHCYL2 MOB1B SCNN1G SLC4A4	2.78e-05	188	139	6	58ccb31cdf43167872ef0fc737e6f9c51ee2e060
ToppCell	COVID-19-kidney-VWF+PLVAP+VCAM1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE2A INSR CHN1 PLEKHG1 DNM3 PBX1	2.87e-05	189	139	6	c121817ddad164e9cfe382c43d0cbc9215508d02
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRINP3 ANK3 MYO1E MOB1B SCNN1G SLC4A4	2.87e-05	189	139	6	fc88c51ace7d883c01617f3f9b5fab70cc91cc09
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 DNM3 PBX1	2.95e-05	190	139	6	656483751e4bf137e4e4bfb2a03a478a8f7fcb63
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DOK6 PDE3A ARHGAP10 APBB2 CHN1 RBMS3	2.95e-05	190	139	6	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	Megakaryocytic-erythropoietic-Megakaryo-cells\|World / Lineage, cell class and subclass	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	2.95e-05	190	139	6	72b61a12ccea506272ce9cef9051aa2612e6ce57
ToppCell	COVID-19-Heart-EC_3\|Heart / Disease (COVID-19 only), tissue and cell type	APBB2 CACHD1 CHN1 PLEKHG1 DNM3 TBCD	2.95e-05	190	139	6	78e7c502b0450c0b37652b1896a2a752fd8a2111
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DOK6 PDE3A ARHGAP10 APBB2 CHN1 RBMS3	2.95e-05	190	139	6	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COLQ CPQ RBMS3 FHOD1 PBX1 ENPEP	3.04e-05	191	139	6	a261f0738d974784bbdd60f23092bfbcca464459
ToppCell	LAM-Epithelial-AT1\|Epithelial / Condition, Lineage and Cell class	UBL3 RHOBTB3 APBB2 RBMS3 PEAK1 ALPP	3.04e-05	191	139	6	3457e15d1e9b36a78363d46b320c4ec46b40290a
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COLQ CPQ RBMS3 FHOD1 PBX1 ENPEP	3.04e-05	191	139	6	6594398cc8151c73696391a43ac110c10283dab1
ToppCell	10x3'2.3-week_17-19-Hematopoietic-MK-early_MK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	DOK6 PDE3A SLC39A4 EVA1B DNM3 PBX1	3.04e-05	191	139	6	3839bf57419d3ec3d4464277bb33301d2b7d701f
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE2A INSR PCDH12 PLEKHG1 DNM3 TBCD	3.04e-05	191	139	6	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ACRBP MOB1B STON2 DNM3 PBX1 SPOCD1	3.13e-05	192	139	6	5bf420b03c32d7bbc919616bcb7d69f3e3a459ed
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE2A INSR CHN1 PLEKHG1 DNM3 PBX1	3.13e-05	192	139	6	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOK6 BRINP3 CHN1 PLEKHG1 SLC4A4 PBX1	3.13e-05	192	139	6	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E PPRC1 RBMS1 FGB PEAK1 LONRF3	3.13e-05	192	139	6	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ACRBP MOB1B STON2 DNM3 PBX1 SPOCD1	3.13e-05	192	139	6	97975340f9ab3ab6e0aa7751b10e008ff3d21bf2
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	DOK6 BRINP3 APBB2 CHN1 RBMS3 PBX1	3.22e-05	193	139	6	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A RBMS1 FAR2 RBMS3 DNM3 PBX1	3.22e-05	193	139	6	456aa8a8f1f9cbba0bd618a5f623909079c0f56b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A INSR PCDH12 CHN1 PLEKHG1 PBX1	3.22e-05	193	139	6	1f978e102a029a6beb10913052cd0a20c7253e8e
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-hematologic-thrombocytic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	3.32e-05	194	139	6	7c38ead538695db1fb1c329ff67d2874aa83c8d2
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1E APBB2 CACHD1 PCDH12 CHN1 PLEKHG1	3.32e-05	194	139	6	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	PND07-28-samps-Mesenchymal\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	RHOBTB3 CPQ RBMS3 PEAK1 PBX1 ENPEP	3.32e-05	194	139	6	68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-hematologic-thrombocytic-platelet\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PDE3A ACRBP STON2 DNM3 PBX1 SPOCD1	3.32e-05	194	139	6	4531639974e363a6ff7ea688325a11407c3efd87
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1E APBB2 CACHD1 PCDH12 CHN1 PLEKHG1	3.32e-05	194	139	6	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 DNM3 PBX1	3.32e-05	194	139	6	e55dc30e200c9f576804acb642175eb4fa9146b5
ToppCell	COVID-19-kidney-PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	PDE2A INSR PCDH12 PLEKHG1 RBMS3 TBCD	3.42e-05	195	139	6	a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EVA1B RBMS3 FHOD1 PEAK1 PBX1 ENPEP	3.42e-05	195	139	6	598b69032a8441a23749b27863d80f7a1fc82a96
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A PCDH12 FAR2 RBMS3 DNM3 PBX1	3.42e-05	195	139	6	23ced69fd904f1d4114b1a7f99f4b5f65ea8824b
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CABP1 BRINP3 PDE3A ARHGAP10 CHN1 SCAI	3.42e-05	195	139	6	787e95fb59c40bba784544b662fac37606ae1427
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 DNM3 PBX1	3.52e-05	196	139	6	023312af38f816a44b407e0daa32590d953caf99
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A CHN1 PLEKHG1 FAR2 RBMS3 TBCD	3.52e-05	196	139	6	145fcf73deba9638b391a1af6c39fa205dc9829f
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A INSR CACHD1 CHN1 PLEKHG1 PBX1	3.52e-05	196	139	6	e224338490691d92c1f70b57112fabdcc92b06a9
Drug	Merbromin [129-16-8]; Down 200; 5uM; HL60; HT_HG-U133A	MYO1E MYOZ3 CTIF PCDH12 COLQ CRYGC EVA1B FGB MAPK7 WDTC1	3.17e-07	199	135	10	2577_DN
Drug	Megestrol acetate [595-33-5]; Up 200; 10.4uM; HL60; HT_HG-U133A	ONECUT2 IFT140 ANK3 TRANK1 UBE3A MCM3AP DNAH17 FGB ENPEP	2.54e-06	195	135	9	3091_UP
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	FAM184A ANK3 MYO1E ARHGAP35 FHOD1 DNAH17 LONRF3 MAPK7 WDTC1	2.65e-06	196	135	9	1684_DN
Drug	Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; PC3; HT_HG-U133A	IFT140 SCN11A ANK3 MFSD6 MYOZ3 KLF3 CTIF PCDH12 SLC4A4	2.77e-06	197	135	9	2061_UP
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	ONECUT2 IFT140 SCN11A ANK3 CTIF ARHGAP35 NEB MAPK7 WDTC1	2.77e-06	197	135	9	2326_DN
Drug	2bub	SERPINA4 SALL1 FGB PBX1 PBX2	3.79e-06	40	135	5	CID005494422
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA	CNTRL KLF3 CTIF FOXN3 ARHGAP35 MAPK7 MXI1 WDTC1	1.69e-05	188	135	8	1023_UP
Drug	Tolazamide [1156-19-0]; Up 200; 12.8uM; HL60; HT_HG-U133A	CABP1 PDE2A ANK3 KLF3 NEB COLQ FGB MAPK7	2.04e-05	193	135	8	2482_UP
Drug	Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; PC3; HT_HG-U133A	IFT140 ANK3 ARHGAP10 MYOZ3 ARHGAP35 PCDH12 DNM3 TBCD	2.04e-05	193	135	8	4671_DN
Drug	Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; PC3; HT_HG-U133A	ONECUT2 ARHGAP10 MYOZ3 CTIF KLHL20 MAPK7 SMG6 WDTC1	2.20e-05	195	135	8	6626_DN
Drug	Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A	ONECUT2 IFT140 CNTRL CTIF ARHGAP35 EVA1B ENPEP WDTC1	2.28e-05	196	135	8	3192_DN
Drug	Estropipate [7280-37-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A	SCN11A MFSD6 DGKQ FOXN3 CPQ ANGPT4 ZNF197 SMG6	2.36e-05	197	135	8	6068_UP
Drug	Aminohippuric acid [61-78-9]; Up 200; 20.6uM; HL60; HT_HG-U133A	IFT140 BCL2L10 APBB2 CTIF F7 MCM3AP SNRNP200 WDTC1	2.36e-05	197	135	8	3076_UP
Drug	Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; HL60; HT_HG-U133A	IFT140 FAM184A RHOBTB3 KLF3 CTIF ARHGAP35 NEB TBCD	2.45e-05	198	135	8	2730_DN
Drug	Methimazole [60-56-0]; Down 200; 35uM; HL60; HT_HG-U133A	ANK3 MYOZ3 CTIF PCDH12 CRYGC FGB MAPK7 SLC4A4	2.45e-05	198	135	8	2570_DN
Drug	Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; MCF7; HT_HG-U133A	IFT140 APBB2 DGKQ ARHGAP35 PCDH12 NEB ENPEP WDTC1	2.54e-05	199	135	8	7171_UP
Drug	Gliclazide [21187-98-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A	SCN11A BCL2L10 CTIF KLHL20 CPQ DNM3 PEAK1 WDTC1	2.54e-05	199	135	8	2870_UP
Drug	Theobromine [83-67-0]; Up 200; 22.2uM; HL60; HT_HG-U133A	MYOZ3 DGKQ ARHGAP35 F7 TRANK1 PEAK1 TBCD SMG6	2.54e-05	199	135	8	2995_UP
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; PC3; HT_HG-U133A	SCN11A FAM184A INSR APBB2 CTIF BAHD1 DNAH17 MAPK7	2.54e-05	199	135	8	6624_DN
Drug	Benzylpenicillin sodium [69-57-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A	BCL2L10 CTIF AHCYL2 NEB ZNF197 FGB SLC4A4 WDTC1	2.63e-05	200	135	8	6839_UP
Drug	CDK2 Inhibitor II	POLB MYOZ3 SCNN1G SMG6 WDTC1	4.22e-05	65	135	5	CID005858639
Drug	T-C-T	INSR SALL1 SACS FGB SERPIND1 ALPP	5.84e-05	113	135	6	CID000447409
Drug	wortmannin; Up 200; 1uM; MCF7; HT_HG-U133A_EA	ANK3 MYO1E CNTRL INSR ATG2B FAM13B MXI1	8.52e-05	175	135	7	869_UP
Drug	Hexetidine [141-94-6]; Up 200; 11.8uM; HL60; HT_HG-U133A	IFT140 BCL2L10 INSR KLF3 DNAH17 SNRNP200 SENP7	1.20e-04	185	135	7	2457_UP
Drug	Gly-pro-arg-pro	SALL1 FGB MLN SERPIND1	1.22e-04	43	135	4	CID000123681
Drug	SR-202	PPRC1 INSR MAPK7	1.30e-04	17	135	3	CID000060910
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A	ANK3 APBB2 AHCYL2 DHX9 CNNM4 SLC4A4 HERC4	1.42e-04	190	135	7	4507_DN
Drug	Yohimbinic acid monohydrate [27801-27-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	ONECUT2 SCN11A RHOBTB3 MCF2L2 RBMS3 PBX1 SNRNP200	1.62e-04	194	135	7	4082_UP
Drug	L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; PC3; HT_HG-U133A	CABP1 ONECUT2 CTIF ARHGAP35 FGB PEAK1 SLC4A4	1.62e-04	194	135	7	5056_UP
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A	ONECUT2 BCL2L10 MYOZ3 CTIF CPQ PEAK1 SLC4A4	1.62e-04	194	135	7	6833_UP
Drug	Mebendazole [31431-39-7]; Down 200; 13.6uM; PC3; HT_HG-U133A	FAM184A MFSD6 APBB2 AHCYL2 CATSPER2 ZNF197 LONRF3	1.62e-04	194	135	7	3671_DN
Drug	(R)-Propranolol hydrochloride [13071-11-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A	CTIF AHCYL2 PCDH12 NEB CRYGC EVA1B FGB	1.67e-04	195	135	7	3553_UP
Drug	Fluocinonide [356-12-7]; Up 200; 8uM; PC3; HT_HG-U133A	CABP1 APBB2 KLF3 UBE3A DNAH17 MLN ALPP	1.67e-04	195	135	7	3757_UP
Drug	Picrotoxinin [17617-45-7]; Down 200; 13.6uM; PC3; HT_HG-U133A	FAM184A ARHGAP10 APBB2 ARHGAP35 DNM3 TBCD WDTC1	1.67e-04	195	135	7	4260_DN
Drug	Lansoprazole [103577-45-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A	ARHGAP10 APBB2 CTIF FOXN3 NEB KLHL20 DNAH17	1.67e-04	195	135	7	3529_UP
Drug	Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; HL60; HT_HG-U133A	IFT140 KLF3 CTIF COLQ CRYGC CPQ AP3D1	1.67e-04	195	135	7	2707_DN
Drug	rotenone; Up 200; 1uM; MCF7; HT_HG-U133A	MYO1E CTIF ARHGAP35 CPQ ZNF197 DNM3 WDTC1	1.67e-04	195	135	7	5943_UP
Drug	Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; HL60; HT_HG-U133A	IFT140 PDE2A ANK3 BCL2L10 APBB2 DNM3 WDTC1	1.72e-04	196	135	7	2913_UP
Drug	alpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A	ONECUT2 SCN11A ANK3 F7 CNNM4 ENPEP SMG6	1.72e-04	196	135	7	2670_UP
Drug	(-)-Cinchonidine [485-71-2]; Up 200; 13.6uM; PC3; HT_HG-U133A	IFT140 SCN11A INSR REL ARHGAP35 NEB SLC4A4	1.72e-04	196	135	7	5833_UP
Drug	Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; PC3; HT_HG-U133A	CABP1 ONECUT2 IFT140 RHOBTB3 ARHGAP35 FGB SLC4A4	1.72e-04	196	135	7	3996_UP
Drug	Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A	ONECUT2 APBB2 AHCYL2 ARHGAP35 CPQ MAPK7 SLC4A4	1.72e-04	196	135	7	4407_DN
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; HL60; HT_HG-U133A	FAM184A APBB2 AHCYL2 ARHGAP35 NEB EVA1B ENPEP	1.72e-04	196	135	7	3049_DN
Drug	PHA-00767505E [723337-45-9]; Down 200; 10uM; PC3; HT_HG-U133A	ONECUT2 CTIF ARHGAP35 DNM3 MLN SLC4A4 TBCD	1.78e-04	197	135	7	6545_DN
Drug	Pentylenetetrazole [54-95-5]; Up 200; 29uM; HL60; HG-U133A	APBB2 KLF3 DENND2D ARHGAP35 FAM13B DHX9 SERPINA4	1.78e-04	197	135	7	1408_UP
Drug	Kawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A	IFT140 INSR APBB2 CTIF FEM1C MAPK7 ENPEP	1.78e-04	197	135	7	4693_DN
Drug	CP-319743 [172078-87-4]; Down 200; 10uM; MCF7; HT_HG-U133A	ONECUT2 APBB2 CTIF AHCYL2 EVA1B LONRF3 MAPK7	1.78e-04	197	135	7	7486_DN
Drug	Pyrilamine maleate [59-33-6]; Up 200; 10uM; MCF7; HT_HG-U133A	SCN11A BCL2L10 DGKQ ARHGAP35 CATSPER2 UBE3A FGB	1.78e-04	197	135	7	7223_UP
Drug	Ioversol [87771-40-2]; Up 200; 5uM; PC3; HT_HG-U133A	CABP1 INSR FOXN3 NEB FGB SLC4A4 SENP7	1.78e-04	197	135	7	6726_UP
Drug	Khellin [82-02-0]; Down 200; 15.4uM; PC3; HT_HG-U133A	CTIF ARHGAP35 NEB F7 DNAH17 ZNF197 FGB	1.83e-04	198	135	7	6641_DN
Drug	Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; HL60; HT_HG-U133A	MYO1E RHOBTB3 KLF3 COLQ DNM3 MAPK7 WDTC1	1.83e-04	198	135	7	3088_DN
Drug	Iopamidol [60166-93-0]; Up 200; 5.2uM; HL60; HT_HG-U133A	RHOBTB3 ARHGAP35 F7 EVA1B DNAH17 MLN SNRNP200	1.83e-04	198	135	7	2732_UP
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HG-U133A	ZC3H14 CNTRL ATG2B USP24 APBB2 CDC42BPB AP3D1	1.83e-04	198	135	7	762_UP
Drug	Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; PC3; HT_HG-U133A	FAM184A ARHGAP10 KLHL20 RBMS3 SLC4A4 TBCD WDTC1	1.83e-04	198	135	7	5099_DN
Drug	Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	IFT140 CNTRL APBB2 CDC42BPB EVA1B HELZ MAPK7	1.83e-04	198	135	7	3175_DN
Drug	15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A	ONECUT2 MFSD6 APBB2 CTIF AHCYL2 CATSPER2 MAPK7	1.83e-04	198	135	7	7489_DN
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; PC3; HT_HG-U133A	IFT140 FAM184A MYOZ3 KLF3 CTIF ARHGAP35 SLC4A4	1.83e-04	198	135	7	4681_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; HL60; HT_HG-U133A	ANK3 APBB2 KLF3 AHCYL2 KLHL20 CPQ ANGPT4	1.83e-04	198	135	7	2554_UP
Drug	Pentamidine isethionate [140-64-7]; Up 200; 6.8uM; HL60; HT_HG-U133A	MYOZ3 KLF3 ARHGAP35 NEB CHN1 COLQ CNNM4	1.83e-04	198	135	7	2473_UP
Drug	Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	ONECUT2 DENND2D ARHGAP35 DHX9 PBX1 HERC4 AP3D1	1.83e-04	198	135	7	4343_UP
Drug	Rolipram [61413-54-5]; Down 200; 14.6uM; HL60; HT_HG-U133A	KLF3 CTIF FOXN3 COLQ EVA1B DNM3 WDTC1	1.83e-04	198	135	7	3072_DN
Drug	Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ARHGAP10 RBM10 NEB KLHL20 EVA1B PEAK1 SLC4A4	1.83e-04	198	135	7	1476_UP
Drug	2-propylpentanoic acid; Up 200; 1000uM; HL60; HT_HG-U133A	ANK3 RHOBTB3 APBB2 KLF3 PCDH12 RBMS3 UBE3A	1.83e-04	198	135	7	6168_UP
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A	CABP1 ONECUT2 APBB2 AHCYL2 ARHGAP35 NEB ENPEP	1.83e-04	198	135	7	7011_UP
Drug	Phenacetin [62-44-2]; Up 200; 22.4uM; HL60; HT_HG-U133A	MYO1E MYOZ3 KLF3 CTIF COLQ MCM3AP MLN	1.89e-04	199	135	7	2471_UP
Drug	Piretanide [55837-27-9]; Down 200; 11uM; PC3; HT_HG-U133A	ARHGAP10 CRYGC TRANK1 CATSPER2 ZNF197 DNM3 SLC4A4	1.89e-04	199	135	7	4490_DN
Drug	cox-2 inhibitor I; Down 200; 10uM; MCF7; HG-U133A	ZC3H14 ARHGAP10 APBB2 CTIF SERPINA4 EVA1B MLN	1.89e-04	199	135	7	207_DN
Drug	Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	IFT140 ARHGAP10 KLF3 FOXN3 KLHL20 PBX1 AP3D1	1.89e-04	199	135	7	7030_DN
Drug	semustine; Down 200; 100uM; MCF7; HT_HG-U133A	ONECUT2 CNTRL MFSD6 CTIF EVA1B LONRF3 SLC4A4	1.89e-04	199	135	7	7487_DN
Drug	Cytisine (-) [485-35-8]; Up 200; 21uM; MCF7; HT_HG-U133A	BCL2L10 CNTRL INSR DGKQ FOXN3 NEB MCM3AP	1.89e-04	199	135	7	6217_UP
Drug	Tiabendazole [148-79-8]; Up 200; 19.8uM; PC3; HT_HG-U133A	CNTRL INSR APBB2 MYOZ3 AHCYL2 ARHGAP35 TRANK1	1.95e-04	200	135	7	4579_UP
Drug	Pirlindole mesylate [60762-57-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A	IFT140 PDE2A CNTRL CRYGC MCM3AP HERC4 AP3D1	1.95e-04	200	135	7	5497_UP
Drug	Tofisopam	PDE2A PDE3A	2.08e-04	4	135	2	DB08811
Drug	methiin	SERPINA4 SACS	2.08e-04	4	135	2	CID000082142
Disease	Ciliopathies	CDH23 TSC2 SCNN1G DNAH8 DNAH11	1.55e-04	110	135	5	C4277690
Disease	DiGeorge syndrome (is_implicated_in)	DVL1P1 DVL1	2.06e-04	5	135	2	DOID:11198 (is_implicated_in)
Disease	neurodegenerative disease (implicated_via_orthology)	DVL1P1 UBQLN1 DVL1 SCNN1G HTT	5.55e-04	145	135	5	DOID:1289 (implicated_via_orthology)
Disease	mean platelet volume	MYO1E KLF3 MCM3 DENND2D CDC42BPB TRANK1 FAR2 DNM3 STIP1 PBX1 TBCD HTT CDK4	8.36e-04	1020	135	13	EFO_0004584
Disease	cerebral cavernous malformation (implicated_via_orthology)	RNF213 CDC42BPB	1.11e-03	11	135	2	DOID:0060669 (implicated_via_orthology)
Disease	progression free survival, urinary bladder cancer	DOK6 IFT140	1.33e-03	12	135	2	EFO_0004920, MONDO_0001187
Disease	type 2 diabetes mellitus (implicated_via_orthology)	INSR F7 PPP1CA PPP1CC	1.40e-03	105	135	4	DOID:9352 (implicated_via_orthology)
Disease	Antihypertensive use measurement	MFSD6 INSR MCM3 PLEKHG1 ENPEP SMG6	1.42e-03	265	135	6	EFO_0009927
Disease	waist-hip ratio	ANK3 RBMS1 INSR HECTD4 DGKQ MEFV MEP1A DNAH17 DNM3 PBX1 AP3D1 HTT SCAI SMG6	1.51e-03	1226	135	14	EFO_0004343
Disease	breast cancer (is_marker_for)	INSR REL TSC2 F7 CDK4	1.65e-03	185	135	5	DOID:1612 (is_marker_for)
Disease	free androgen index	PDE2A ARHGAP10 INSR FOXN3 DENND2D CATSPER2 RBMS3	1.72e-03	374	135	7	EFO_0007005
Disease	receptive language perception, parental genotype effect measurement	PLEKHG1 SCNN1G	1.82e-03	14	135	2	EFO_0005686, EFO_0005939
Disease	Drug habituation	FAM184A INSR PBX1 DNAH8	1.96e-03	115	135	4	C0013170
Disease	Drug abuse	FAM184A INSR PBX1 DNAH8	1.96e-03	115	135	4	C0013146
Disease	Prescription Drug Abuse	FAM184A INSR PBX1 DNAH8	1.96e-03	115	135	4	C4316881
Disease	Substance-Related Disorders	FAM184A INSR PBX1 DNAH8	1.96e-03	115	135	4	C0236969
Disease	Drug Use Disorders	FAM184A INSR PBX1 DNAH8	1.96e-03	115	135	4	C0013222
Disease	Drug Dependence	FAM184A INSR PBX1 DNAH8	1.96e-03	115	135	4	C1510472
Disease	Substance Dependence	FAM184A INSR PBX1 DNAH8	1.96e-03	115	135	4	C0038580
Disease	Substance Use Disorders	FAM184A INSR PBX1 DNAH8	1.96e-03	115	135	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	FAM184A INSR PBX1 DNAH8	1.96e-03	115	135	4	C0029231
Disease	Substance abuse problem	FAM184A INSR PBX1 DNAH8	2.02e-03	116	135	4	C0740858
Disease	Ischemic stroke, tissue plasminogen activator measurement	HECTD4 FGB	2.10e-03	15	135	2	EFO_0004791, HP_0002140
Disease	Ischemic stroke, plasminogen activator inhibitor 1 measurement	HECTD4 FGB	2.39e-03	16	135	2	EFO_0004792, HP_0002140
Disease	multiple myeloma (is_implicated_in)	BCL2L10 MEFV XPO5	2.53e-03	59	135	3	DOID:9538 (is_implicated_in)
Disease	factor XI measurement, Ischemic stroke	HECTD4 FGB	2.70e-03	17	135	2	EFO_0004694, HP_0002140
Disease	systolic blood pressure, alcohol drinking	PDE3A INSR HECTD4 PLEKHG1	2.89e-03	128	135	4	EFO_0004329, EFO_0006335
Disease	lymphocyte count	PIK3AP1 RBMS1 HECTD4 CDH23 KLF3 PPP1CC TAF8 MCM3AP DNAH17 HELZ STIP1 PBX1 AP3D1 HTT SMG6	2.92e-03	1464	135	15	EFO_0004587
Disease	migraine disorder, systolic blood pressure	RNF213 SMG6	3.03e-03	18	135	2	EFO_0006335, MONDO_0005277
Disease	transitional cell carcinoma (is_marker_for)	REL XPO5 CDK4	3.04e-03	63	135	3	DOID:2671 (is_marker_for)
Disease	serum gamma-glutamyl transferase measurement	PIK3AP1 CABP1 ARHGAP10 HECTD4 ARHGAP35 CDC42BPB TRANK1 SALL1 CATSPER2 RBMS3 MXI1	3.26e-03	914	135	11	EFO_0004532
Disease	cerebral infarction (is_marker_for)	BRINP3 F7	3.38e-03	19	135	2	DOID:3526 (is_marker_for)
Disease	cup-to-disc ratio measurement	ANK3 ARHGAP35 SALL1 RBMS3 HELZ HERC4 MXI1	3.73e-03	430	135	7	EFO_0006939
Disease	Ischemic stroke	PDE3A GALNT1 FOXN3 FGB ENPEP DNAH11	3.85e-03	324	135	6	HP_0002140
Disease	insomnia measurement	PDE2A BRINP3 ARHGAP10 MFSD6 SALL1 MLN DNAH11	4.38e-03	443	135	7	EFO_0007876
Disease	progranulin measurement	UBQLN1 CDH23	4.52e-03	22	135	2	EFO_0004625
Disease	Bronchiectasis	SCNN1G DNAH11	4.52e-03	22	135	2	C0006267
Disease	body weight loss	FOXN3 SALL1	4.52e-03	22	135	2	EFO_0005245

Protein segments in the cluster

Peptide	Gene	Start	Entry
EDHSQMRQMELEIRP	SMG6	1231	Q86US8
CPSMDIQAMEENLLR	BRINP3	291	Q76B58
MEPDEQLRNDHMNLR	CNTRL	416	Q7Z7A1
ARAIMEEVMSLLQPL	CPQ	381	Q9Y646
NDMLSLVDPMDRSVL	APBB2	476	Q92870
ELAPAELEMLSRSLM	CCDC88B	196	A6NC98
ENLPGLMEMDQDDRV	CATSPER2	476	Q96P56
TGRLLEEQLPEMMTE	CTIF	531	O43310
EEQLPEMMTELLASA	CTIF	536	O43310
MVDQLRERTTMADPL	BCL2L10	1	Q9HD36
ESTPMIMENIQELIR	ACRBP	276	Q8NEB7
TLNRDINMMDILTTP	MASTL	181	Q96GX5
PLAAQEMSVRMSNLE	CACHD1	1131	Q5VU97
VQRTMLMDEQPLLDR	DGKQ	456	P52824
ALEEEMLQMQESTRL	DNAH11	1291	Q96DT5
LEEFMNPSLTEDELM	DNAH11	4161	Q96DT5
DMMTNQRDEELPTLL	PIK3AP1	326	Q6ZUJ8
PTEMELIELSQQINM	CABP1	261	Q9NZU7
VRLPDDMSALQMAII	CDH23	3056	Q9H251
LMRESKPEDIQMITE	FAM184A	981	Q8NB25
SPRMDLTLAELQEMA	TP53BP2	121	Q13625
LPEADQQMLRDLMSD	ATG2B	1401	Q96BY7
PDLARDLANDIMTLM	AP3D1	141	O14617
VMLRMLPQAATEDDI	RBM10	131	P98175
SNLPLSMDEQELENM	RBMS1	146	P29558
NLPISMDEQELENML	RBMS3	146	Q6XE24
LLEMLLEQRSSMPVE	PCDH12	1116	Q9NPG4
DALENIDPATQMMIL	SERPIND1	276	P05546
DLLSQAVMMVENSRP	KIAA0895L	246	Q68EN5
TLMRPQEETVAALMD	ARHGAP10	541	A1A4S6
LIADPDEMRMQALLI	FEM1C	311	Q96JP0
TEMLMSELSPEDQRV	FAR2	406	Q96K12
DIESLQREIQMDSPM	MAPK7	791	Q13164
QREIQMDSPMLLADL	MAPK7	796	Q13164
TDPQLMRLDNMLLAE	PBX1	101	P40424
LMDLETPEEMQARSL	C19orf81	26	C9J6K1
NLMLELETSQSPCMQ	COLQ	81	Q9Y215
VDPQLMRLDNMLLAE	PBX2	111	P40425
LQQPLMVSLSEEMEN	KLF3	161	P57682
SDLARDMLMQERITP	LEXM	386	Q3ZCV2
NNMDQTVMVPSLLRD	MID1IP1	26	Q9NPA3
MPEVVQLRMTENILE	FAM13B	261	Q9NYF5
SPQSDMMREQLQLSE	MCM3AP	1926	O60318
MGNREMEELIPLVNR	DNM3	1	Q9UQ16
DEIMQQEVRPLMAVE	MCF2L2	26	Q86YR7
QLTRMGPTELLIEME	FGB	331	P02675
EDDMLDMAPLLQENS	FDX2	136	Q6P4F2
PEDDTSMAILSMLQD	PDE2A	611	O00408
PLVMDNLDSIMEQLN	PDE3A	676	Q14432
DEELLAMEIRMRGQP	PEAK1	256	Q9H792
MIPSLDDIQQAINRM	DNAH8	896	Q96JB1
ELMPDVGRSMQQLLD	HERC4	836	Q5GLZ8
IIRPQKQEMTDDMDS	GLYATL1	56	Q969I3
TLMRDERGLPAMNNL	ONECUT2	196	O95948
ETLRSEMEMFNVPEL	MEFV	576	O15553
LRMAVMLPEGEDLNE	MOB1B	41	Q7L9L4
MRDQMLLEDVLPVQE	ENPEP	436	Q07075
PTLQEMIQMAAEIAD	INSR	1131	P06213
EMLRDPELRSKMISN	CDC42BPB	1571	Q9Y5S2
QLLTMLSPLEMELRT	HECTD4	3851	Q9Y4D8
LQPQTGEITNRMMDL	MFSD6	226	Q6ZSS7
LEPVLMQRVMIDAAS	HELZ	371	P42694
DQMRSAEQTRLMPAE	PASD1	751	Q8IV76
MVRILIMDINDNAPE	PCDHB4	226	Q9Y5E5
LLFIMLDQMDPEQDR	MCM3	481	P25205
LDPSLMEMTEAALRL	ALPP	306	P05187
MEMTEAALRLLSRNP	ALPP	311	P05187
LSPDLQSMEQIRRIM	PPP1CA	176	P62136
PLMVSDRMDLDTLAR	ITPRIPL1	26	Q6GPH6
LMASEMIALNRSLPD	GALNT1	86	Q10472
MIINEELMASLDQPT	EIF3CL	826	B5ME19
MDAPRRDMELLSNSL	EVA1B	1	Q9NVM1
SSMAQLPMEELNRIQ	HTT	2026	P42858
MESEEFMLLPANQLI	KLHL20	201	Q9Y2M5
MEDEVENIISSMRPQ	DNAH17	2886	Q9UFH2
MEQKARLQTSLTEPM	DOK6	241	Q6PKX4
VPEMEESGAQLLLEM	CDK4	261	P11802
MAVRMIQNSPDNIEL	FRMPD2	841	Q68DX3
LLQDPDIDAASAMML	FOXN3	246	O00409
EALITDPDEMRMQAL	FEM1A	361	Q9BSK4
IIRPQKQEMTDDMDS	GLYATL1B	56	A0A0U1RQE8
LTGRREPLQMEDSNM	BAHD1	16	Q8TBE0
LLNQTSRMDAQMPET	ANGPT4	156	Q9Y264
DLMRMTAILQTDVPE	ANK3	1911	Q12955
SRMEPMNLLVDDPNE	DUXB	161	A0A1W2PPF3
LMMELSEDCPSIQDR	CRYGC	101	P07315
VMQLPDSGLEIRDRM	DVL1	421	O14640
AEALMMPLVDQLENR	HEATR1	2016	Q9H583
LLTMMPTEEERQKIE	FHOD1	736	Q9Y613
LMRSPELDAMAALND	CHN1	426	P15882
VMQLPDSGLEIRDRM	DVL1P1	396	P54792
IMESPANSIEMLLSN	SCNN1G	516	P51170
LPLEMSSIAALENQM	SALL1	856	Q9NSC2
RNMDIRENLLDPGMA	SACS	1501	Q9NZJ4
PREEMLQMQDIVLNE	POLB	151	P06746
MNLALLSSPEDMIEA	IFT140	1056	Q96RY7
EELMLQDETLLGTMQ	PPRC1	81	Q5VV67
ISQLDPVNERMLNMI	DHX9	1121	Q08211
EVMDSPMEEVLLVNL	DENND2D	316	Q9H6A0
MPSRELASMNLDIVD	RHOBTB3	521	O94955
DLLRENSMLQEEIAM	POTEC	521	B2RU33
ALLPSELEMQQMEET	TAF8	226	Q7Z7C8
NISSIMPSNEMDLQL	SENP7	506	Q9BQF6
IEIAEQEMPALMALR	AHCYL2	201	Q96HN2
QQIMSDPAMRLILEQ	STIP1	496	P31948
RLNSMLMEVEEPEVL	NBPF14	841	Q5TI25
ELMVLNVPRLMTQDC	F7	356	P08709
DENTTVRVPMMLQDQ	SERPINA4	236	P29622
LDQEPDVRNRMSSSM	MEP1A	511	Q16819
EVPMTLAELSALMQR	SLC39A4	216	Q6P5W5
NMENERIPFDLMDTV	ARHGAP35	396	Q9NRY4
QDRLMDLPVLSMDLS	STON2	546	Q8WXE9
LMALDPMELRIVQNC	CNNM4	206	Q6P4Q7
DTMLLNIPLVMNNER	RNF213	3671	Q63HN8
CPLAQLMDSETDMVR	VPS51	81	Q9UID3
NQRRMNADPLEVMLL	WDTC1	631	Q8N5D0
RMAEDTSPNMNDNIL	SUN5	36	Q8TC36
EENPRNQLMALMLLT	ZNF197	196	O14709
ALVRLEMIAMENPAD	UBE3A	536	Q05086
APLEIGMRMNSRQLE	MLN	81	P12872
MSSNVPADMINLRLI	UBL3	1	O95164
DLVRMSSMQLAPQEL	SPOCD1	691	Q6ZMY3
RQTLELARNPAMMQE	UBQLN1	236	Q9UMX0
PESQEMLEEQLVRML	XPO5	951	Q9HAV4
LQALEREPMNLASQM	SCAI	301	Q8N9R8
MQLRRPSDQEVSESM	REL	261	Q04864
MGETDNPRLLSMNLE	REL	506	Q04864
LSPDLQSMEQIRRIM	PPP1CC	176	P36873
PSMQDLLEEASSRDM	ZNF333	86	Q96JL9
MEMEDEERNALLQLT	SNRNP200	1986	O75643
EMEQLRISPATMLED	USP24	1526	Q9UPU5
MLDREASSLPQLVEM	SLC4A4	171	Q9Y6R1
QFLVMDLPMVSEDRL	SCN11A	1666	Q9UI33
PIQLMDRLSNESIML	STRCP1	1266	A6NGW2
MMNLLLDIVQDQTSP	TBCD	81	Q9BTW9
LESRLDLIAQQMMPE	ATP6V1E1	196	P36543
LNRLSLASEMPLMDN	PLEKHG1	931	Q9ULL1
REIESRLQLMSMDCP	TRANK1	2546	O15050
RLQIDPVMAETLQMS	ZC3H14	436	Q6PJT7
EELDMDVMRPLINEQ	SLC36A4	16	Q6YBV0
MPLQELSNALMAAER	TSC2	1226	P49815
MESVRIEQMLSLPAE	LONRF3	1	Q496Y0
QLQGPQEMERIRMDS	MXI1	146	P50539
LFMDLIELMQSSELP	MYO1E	526	Q12965
SVPQDLMMEELSLRN	MYOZ3	31	Q8TDC0
LLPDAMNIELTRNMN	NEB	2146	P20929